By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Flexion Therapeutics 

300 TradeCenter
Suite 2460
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-897-9977 Fax: 781-897-9970



Company News
Flexion (FLXN) Announces New Drug Application For Zilretta (FX006) Accepted By U.S. FDA 2/7/2017 12:20:34 PM
Flexion (FLXN) Submits New Drug Application For Zilretta To Treat Knee Osteoarthritis Pain 12/13/2016 3:45:57 PM
Flexion (FLXN) Reports Third Quarter 2016 Financial Results 11/8/2016 7:30:49 AM
Flexion (FLXN) Reports Primary Endpoint Met In Clinical Trial Evaluating Investigational Drug Candidate Zilretta In Type 2 Diabetes Patients With Knee Osteoarthritis 11/2/2016 10:24:41 AM
Flexion (FLXN) Adds Three New Executives In Key Roles To Support The Planned Commercial Launch Of Zilretta 7/6/2016 8:40:54 AM
Flexion (FLXN) Receives Positive Guidance From FDA On New Drug Application (NDA) Submission For Zilretta For Osteoarthritis Of The Knee 5/26/2016 8:07:41 AM
Cytel Congratulates Flexion (FLXN) On Release Of Phase III Data For Zilretta 5/5/2016 10:54:14 AM
Flexion (FLXN) To Report First-Quarter 2016 Financial Results On May 12, 2016 5/5/2016 8:37:07 AM
3 Stories Of Pharma Outsourcing: Wellstat Therapeutics, Ramsey Lake, And Flexion (FLXN) 4/5/2016 7:09:03 AM
Flexion (FLXN) Announces Presentation Of Results From Pivotal Phase IIb And Phase III Clinical Trials For Zilretta At Osteoarthritis Research Society International (OARSI) 2016 World Congress 4/4/2016 8:16:13 AM